CSI: Abbott to Acquire Cardiovascular Systems

Abbott (NYSE: ABT), acquired Cardiovascular Systems, a St. Paul, MN-based medical device company. Under terms of the agreement, CSI stockholders will receive $20 per common share at a total expected equity value of approximately $890 million. With the acquisition, Abbott will gain an innovative, complementary solution in treating vascular disease through CSI's atherectomy system, which prepares vessels for angioplasty [...]The post Abbott to Acquire Cardiovascular Systems appeared first on FinSMEs.